The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Magellan Health Inc

Nasdaq: MGLN
Last

(U.S.) $66.60

Today's change-0.35 -0.52%
Updated March 29 4:00 PM EDT. Delayed by at least 15 minutes.
 

Magellan Health Inc

Nasdaq: MGLN
Last

(U.S.) $66.60

Today's change-0.35 -0.52%
Updated March 29 4:00 PM EDT. Delayed by at least 15 minutes.

Magellan Health Inc down (U.S.)$0.35

Magellan Health Inc closed lower Wednesday, dropping (U.S.)$0.35 or 0.52% to (U.S.)$66.60. Over the last five days, shares have gained 3.02%, but are down 11.50% for the last year to date. Shares have underperformed the S&P 500 by 17.40% during the last year.

Key company metrics

  • Open(U.S.) $66.85
  • Previous close(U.S.) $66.95
  • High(U.S.) $66.85
  • Low(U.S.) $66.25
  • Bid / Ask(U.S.) $0.00 / (U.S.) $69.95
  • YTD % change-11.50%
  • Volume110,683
  • Average volume (10-day)141,513
  • Average volume (1-month)166,535
  • Average volume (3-month)187,554
  • 52-week range(U.S.) $49.50 to (U.S.) $84.71
  • Beta0.68
  • Trailing P/E20.29×
  • P/E 1 year forward16.20×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $3.28
Updated March 29 4:00 PM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue1,2631,2921,1641,117
Total other revenue--------
Total revenue1,2631,2921,1641,117
Gross profit94734151
Total cost of revenue1,1701,2191,1241,066
Total operating expense1,1981,2461,1491,091
Selling / general / administrative--------
Research & development--------
Depreciation / amortization29272625
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income65461526
Interest income (expense), net non-operating-3-3-2-2
Gain (loss) on sale of assets--------
Other--------
Income before tax62441425
Income after tax3625113
Income tax, total26191312
Net income3526413
Total adjustments to net income--------
Net income before extra. items3526413
Minority interest-1030
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items3526413
Inc. avail. to common incl. extra. items3526413
Diluted net income3526413
Dilution adjustment--------
Diluted weighted average shares24242424
Diluted EPS excluding extraordinary itemsvalue per share1.491.060.170.56
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share1.491.060.170.56